Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety, Tolerability and Pharmacokinetics of Single Dose of PB-119 in Healthy Volunteers

Trial Profile

Safety, Tolerability and Pharmacokinetics of Single Dose of PB-119 in Healthy Volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 31 Jan 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Exenatide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Sponsors PegBio
  • Most Recent Events

    • 31 Jan 2020 Results published in the European Journal of Drug Metabolism and Pharmacokinetics
    • 13 Feb 2017 Status changed from active, no longer recruiting to completed.
    • 09 Jun 2015 Status changed from recruiting to active, no longer recruiting as results presented at the 75th Annual Scientific Sessions of the American Diabetes Association
Restricted Access

If your organization has a subscription then there are several options available to help you access AdisInsight while working remotely. Contact us at AsktheExpert.AdisInsight@springer.com to find out more.
Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top